REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tower Research Capital LLC (TRC) | 3,273 | $82,840 | 0.00% |
AMALGAMATED BANK | 12,583 | $318 | 0.00% |
Elequin Capital, LP | 264 | $6,682 | 0.00% |
Russell Investments Group, Ltd. | 58,675 | $1,485,062 | 0.00% |
Capital Advisors, Ltd. LLC | 760 | $19 | 0.00% |
VANGUARD GROUP INC | 4,652,776 | $117,761,761 | 0.00% |
FIRST TRUST ADVISORS LP | 108,916 | $2,756,663 | 0.00% |
Calamos Advisors LLC | 24,923 | $630,801 | 0.00% |
Bank of New York Mellon Corp | 372,509 | $9,428,203 | 0.00% |
MORGAN STANLEY | 639,756 | $16,192,226 | 0.00% |
Cubist Systematic Strategies, LLC | 13,000 | $329,030 | 0.00% |
Handelsbanken Fonder AB | 13,500 | $342 | 0.00% |
Ensign Peak Advisors, Inc | 37,000 | $936,470 | 0.00% |
Zurcher Kantonalbank (Zurich Cantonalbank) | 15,461 | $391,318 | 0.00% |
Mirae Asset Global Investments Co., Ltd. | 37,731 | $954,972 | 0.00% |
Leucadia National | 8,166 | $206,681 | 0.00% |
AMERIPRISE FINANCIAL INC | 213,116 | $5,393,966 | 0.00% |
Squarepoint Ops LLC | 32,206 | $815,134 | 0.00% |
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 15,252 | $386 | 0.00% |
Citadel Advisors | 121,400 | $3,072,634 | 0.00% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.